洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2400093848】Management of acne scars by sequential combination of micro-needle radiofrequency followed by fractional CO2 laser versus each therapy alone

基本信息
登记号

ChiCTR2400093848

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2024-12-12

临床申请受理号

/

靶点

/

适应症

Acne scar

试验通俗题目

Management of acne scars by sequential combination of micro-needle radiofrequency followed by fractional CO2 laser versus each therapy alone

试验专业题目

Management of acne scars by sequential combination of micro-needle radiofrequency followed by fractional CO2 laser versus each therapy alone

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

41002

联系人通讯地址
临床试验信息
试验目的

In this study, we propose to evaluate the effectiveness of a sequential combination of MNRF followed by FCO2 laser compared to each therapy alone in treating acne sc

试验分类
试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

Random number table

盲法

None

试验项目经费来源

University of Mosul

试验范围

/

目标入组人数

15

实际入组人数

/

第一例入组时间

2022-10-01

试验终止时间

2024-10-01

是否属于一致性

/

入选标准

Forty-five patients suffering from various forms and severity of acne scars (box scar, ice pick scar, atrophic, and rolling atrophic scar).;

排除标准

Active acne lesions, hypertrophic and keloid scars, active herpes simplex, immunocompromised individuals, breast-feeding or pregnancy, recent isotretinoin use, coagulation issues, heart problems, and rejection of post-treatment evaluation were among the exclusion criteria.;

研究者信息
研究负责人姓名
试验机构

University of Mosul

研究负责人电话
研究负责人邮箱
研究负责人邮编

41002

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品